Northwestern Mutual Investment Management Company’s Juno Therapeutics, Inc. JUNO Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,400	Closed	-$62K	–	1054
2015 Q4	$62K	Hold	1,400	–	–	﹤0.01%	789
2015 Q3	$57K	Hold	1,400	–	–	﹤0.01%	803
2015 Q2	$75K	Buy	+1,400	New	+$74.3K	﹤0.01%	819

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Northwestern Mutual Investment Management Company's JUNO Position: Q1 2016 in Review

Northwestern Mutual Investment Management Company sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2016, closing a stake of 1,400 shares — an estimated $62K sold.

Northwestern Mutual Investment Management Company first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $75K in Q2 2015. 158 funds tracked by Wall St. Rank hold JUNO as of Q1 2016.

Northwestern Mutual Investment Management Company reported no remaining Juno Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
Northwestern Mutual Investment Management Company sold 1,400 Juno Therapeutics, Inc. shares in Q1 2016, an estimated $62K.
Northwestern Mutual Investment Management Company first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
Northwestern Mutual Investment Management Company's Juno Therapeutics, Inc. position peaked at $75K in Q2 2015.
158 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2016.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2016, filed 16 May 2016.